An interventional study of SNaP Advanced Wound Care System and SNaP in Ulcer and Wounds and Injuries, sponsored by Stanford University. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-12-13.
Sponsored by Stanford University · Not applicable, Interventional, and Treatment
The purpose of this study is to evaluate the feasibility and usability of a new portable and compact wound dressing device for the treatment of small chronic skin wounds.
This is an open label study
5,056 studies on the registry are indexed under Wounds and Injuries; 861 are open to participants now.
This study's enrollment of 12 is below the median of 52 across 3,239 interventional studies indexed under Wounds and Injuries.
Browse Wounds and Injuries studies →Stanford University is the lead sponsor of 2,117 studies on the registry; 425 are open to participants now.
Of its 259 completed or terminated interventional studies of FDA-regulated products, 197 (76%) have results posted.
Counted across the registry records on this site, refreshed daily.
Inclusion Criteria:- Venous stasis ulcer or other chronic wound on the lower extremity that is >1.5cm and \<10cm at widest point
Exclusion Criteria:- Active wound infection.
This is an "open label" pilot study of SNaP Advanced Wound Care System
Device: SNaP Advanced Wound Care System · Other: SNaP
Application of negative pressure device daily per instructions
Also known as: SNaP device (SmartNegative Pressure device)
Daily use
Also known as: SNaP device
Daily application per protocol
Ease of Use for Patients
Participants were given instructions to use the SNaP device home. Participants completed a questionnaire reporting whether the device was easy to use, worthwhile to use, and whether they would use the device again. Numbers responding positively to each question are presented.
Time frame: Baseline up to 31 days
| Milestone | SNaP Application |
|---|---|
| Started | 12 |
| Completed | 6 |
| Not completed | 6 |
Participants were given instructions to use the SNaP device home. Participants completed a questionnaire reporting whether the device was easy to use, worthwhile to use, and whether they would use the device again. Numbers responding positively to each question are presented.
| participants | Open Label Single Arm Study |
|---|---|
| Easy to use | 8 |
| Worthwhile to use | 10 |
| I would use this device again | 9 |
Collected over 1 month. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Eligible Participants | — | 0/12 (0%) | 4/12 (33.3%) |
| Event | Eligible Participants |
|---|---|
| ipsilateral knee painMusculoskeletal and connective tissue disorders | 3/11 |
| wound painSkin and subcutaneous tissue disorders | 3/12 |
12
| Age, Categorical(Participants) | Open Label Single Arm Study |
|---|---|
| <=18 years | 0 |
| Between 18 and 65 years | 9 |
| >=65 years | 3 |
| Age, Continuous(years) | Open Label Single Arm Study |
|---|---|
| Median | 55 (18 to 86) |
| Sex: Female, Male(Participants) | Open Label Single Arm Study |
|---|---|
| Female | 7 |
| Male | 5 |
| Region of Enrollment(participants) | Open Label Single Arm Study |
|---|---|
| United States | 12 |
Plan to share: No — No sharing
This study is completed, as verified in Nov 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Stanford University